SOTALOL

This brand name is authorized in Netherlands

Active ingredients

The drug SOTALOL contains one active pharmaceutical ingredient (API):

1 Sotalol UNII HEC37C70XX - SOTALOL HYDROCHLORIDE

D,l-sotalol is a non-selective hydrophilic β-adrenergic receptor blocking agent, devoid of intrinsic sympathomimetic activity or membrane stabilizing activity. Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. Read about Sotalol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOTALOL Tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AA07	Sotalol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 14990, 25232, 2879, 84239